S&P 500   2,742.13 (+3.11%)
DOW   23,362.13 (+3.13%)
QQQ   200.31 (+1.99%)
AAPL   265.16 (+2.21%)
FB   173.27 (+2.63%)
MSFT   165.74 (+1.38%)
GOOGL   1,206.71 (+2.04%)
AMZN   2,032.48 (+1.04%)
CGC   15.03 (+3.65%)
NVDA   267.18 (+3.15%)
BABA   194.85 (-1.60%)
MU   48.26 (+3.70%)
GE   7.26 (+3.27%)
TSLA   545.20 (-0.05%)
T   29.55 (-1.89%)
ACB   0.85 (+6.22%)
F   5.00 (+6.16%)
NFLX   371.43 (-0.23%)
BAC   23.14 (+4.52%)
GILD   74.81 (+0.19%)
DIS   100.11 (-1.12%)
PRI   96.39 (+9.46%)
S&P 500   2,742.13 (+3.11%)
DOW   23,362.13 (+3.13%)
QQQ   200.31 (+1.99%)
AAPL   265.16 (+2.21%)
FB   173.27 (+2.63%)
MSFT   165.74 (+1.38%)
GOOGL   1,206.71 (+2.04%)
AMZN   2,032.48 (+1.04%)
CGC   15.03 (+3.65%)
NVDA   267.18 (+3.15%)
BABA   194.85 (-1.60%)
MU   48.26 (+3.70%)
GE   7.26 (+3.27%)
TSLA   545.20 (-0.05%)
T   29.55 (-1.89%)
ACB   0.85 (+6.22%)
F   5.00 (+6.16%)
NFLX   371.43 (-0.23%)
BAC   23.14 (+4.52%)
GILD   74.81 (+0.19%)
DIS   100.11 (-1.12%)
PRI   96.39 (+9.46%)
S&P 500   2,742.13 (+3.11%)
DOW   23,362.13 (+3.13%)
QQQ   200.31 (+1.99%)
AAPL   265.16 (+2.21%)
FB   173.27 (+2.63%)
MSFT   165.74 (+1.38%)
GOOGL   1,206.71 (+2.04%)
AMZN   2,032.48 (+1.04%)
CGC   15.03 (+3.65%)
NVDA   267.18 (+3.15%)
BABA   194.85 (-1.60%)
MU   48.26 (+3.70%)
GE   7.26 (+3.27%)
TSLA   545.20 (-0.05%)
T   29.55 (-1.89%)
ACB   0.85 (+6.22%)
F   5.00 (+6.16%)
NFLX   371.43 (-0.23%)
BAC   23.14 (+4.52%)
GILD   74.81 (+0.19%)
DIS   100.11 (-1.12%)
PRI   96.39 (+9.46%)
S&P 500   2,742.13 (+3.11%)
DOW   23,362.13 (+3.13%)
QQQ   200.31 (+1.99%)
AAPL   265.16 (+2.21%)
FB   173.27 (+2.63%)
MSFT   165.74 (+1.38%)
GOOGL   1,206.71 (+2.04%)
AMZN   2,032.48 (+1.04%)
CGC   15.03 (+3.65%)
NVDA   267.18 (+3.15%)
BABA   194.85 (-1.60%)
MU   48.26 (+3.70%)
GE   7.26 (+3.27%)
TSLA   545.20 (-0.05%)
T   29.55 (-1.89%)
ACB   0.85 (+6.22%)
F   5.00 (+6.16%)
NFLX   371.43 (-0.23%)
BAC   23.14 (+4.52%)
GILD   74.81 (+0.19%)
DIS   100.11 (-1.12%)
PRI   96.39 (+9.46%)
Log in

NYSEAMERICAN:NSPRInspireMD Stock Price, Forecast & News

$0.60
+0.02 (+3.43 %)
(As of 04/8/2020 02:52 PM ET)
Add
Compare
Today's Range
$0.56
Now: $0.60
$0.62
50-Day Range
$1.34
MA: $2.42
$3.59
52-Week Range
$0.48
Now: $0.60
$7.51
Volume35,305 shs
Average Volume218,879 shs
Market Capitalization$2.62 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
Read More
InspireMD logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.20 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:NSPR
Previous SymbolNASDAQ:NSPR
CUSIPN/A
Phone+1-857-4536553

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees43
Market Cap$2.62 million
Next Earnings Date5/12/2020 (Estimated)
OptionableNot Optionable

Receive NSPR News and Ratings via Email

Sign-up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.


InspireMD (NYSEAMERICAN:NSPR) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of InspireMD?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for InspireMD.

When is InspireMD's next earnings date?

InspireMD is scheduled to release its next quarterly earnings announcement on Tuesday, May 12th 2020. View our earnings forecast for InspireMD.

How were InspireMD's earnings last quarter?

InspireMD Inc (NYSEAMERICAN:NSPR) issued its quarterly earnings data on Tuesday, March, 10th. The medical equipment provider reported ($0.57) EPS for the quarter, hitting analysts' consensus estimates of ($0.57). The medical equipment provider had revenue of $1.01 million for the quarter. View InspireMD's earnings history.

When did InspireMD's stock split? How did InspireMD's stock split work?

InspireMD's stock reverse split on Monday, April 1st 2019. The 1-50 reverse split was announced on Tuesday, March 26th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 29th 2019. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 2 shares after the split.

What price target have analysts set for NSPR?

1 brokers have issued twelve-month price objectives for InspireMD's stock. Their forecasts range from $2.00 to $2.00. On average, they anticipate InspireMD's stock price to reach $2.00 in the next year. This suggests a possible upside of 231.4% from the stock's current price. View analysts' price targets for InspireMD.

What are Wall Street analysts saying about InspireMD stock?

Here are some recent quotes from research analysts about InspireMD stock:
  • 1. According to Zacks Investment Research, "InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel. " (3/31/2020)
  • 2. HC Wainwright analysts commented, "Our $5 PT was derived by using a 25% weighted-average cost of capital to discount free cash flows we project 2019-2030, and dividing them by our projected number of shares for each year to account for the effects of share dilution, and then ascribing a 1% terminal growth rate and 75% probability of." (8/19/2019)

Has InspireMD been receiving favorable news coverage?

News stories about NSPR stock have been trending very negative on Wednesday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. InspireMD earned a coverage optimism score of -3.3 on InfoTrie's scale. They also gave news articles about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutInspireMD.

Are investors shorting InspireMD?

InspireMD saw a decline in short interest during the month of February. As of February 28th, there was short interest totaling 91,200 shares, a decline of 39.5% from the February 13th total of 150,700 shares. Based on an average trading volume of 228,600 shares, the short-interest ratio is presently 0.4 days. Approximately 7.9% of the shares of the company are sold short. View InspireMD's Current Options Chain.

Who are some of InspireMD's key competitors?

What other stocks do shareholders of InspireMD own?

Who are InspireMD's key executives?

InspireMD's management team includes the following people:
  • Dr. James J. Barry, Pres, CEO & Director (Age 60)
  • Mr. Craig Shore, CFO, Chief Admin. Officer, Sec. & Treasurer (Age 58)
  • Mr. Agustin V. Gago, Exec. VP & Chief Commercial Officer (Age 59)
  • Mr. Roei Samuri, VP of Operations
  • Dr. Sol J. Barer, Special Advisor to the Board (Age 72)

What is InspireMD's stock symbol?

InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR."

How do I buy shares of InspireMD?

Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is InspireMD's stock price today?

One share of NSPR stock can currently be purchased for approximately $0.60.

How big of a company is InspireMD?

InspireMD has a market capitalization of $2.62 million. InspireMD employs 43 workers across the globe. View additional information about InspireMD.

What is InspireMD's official website?

The official website for InspireMD is http://www.inspiremd.com/.

How can I contact InspireMD?

InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553.

This page was last updated on 4/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel